Is Seleniso currently covered by health insurance?
Selinexor (Selinexor) is currently on the Chinese market and has been successfully included in medical insurance. Since its introduction, it has been widely used to treat multiple myeloma and certain types of lymphoma, especially when traditional treatments have failed. Patients can purchase the drug through domestic hospitals and pharmacies and enjoy the support of medical insurance reimbursement policies, which provides patients with a more convenient treatment path.
Although Seleniso is covered by medical insurance, its price is relatively high. According to the current market conditions, the price of Seleniso's original drug is approximately between RMB 5,000 and RMB 10,000. The specific price may vary depending on the region and hospital. When purchasing, patients should consult the local hospital pharmacy to learn about detailed medical insurance reimbursement and specific costs to ensure that the treatment plan is suitable for their own financial conditions.
It is worth noting that there are also relatively cheaper generics of selinesol on foreign markets, especially those from Laos. The price of the Lao version of generic drugs is about more than 2,000 yuan, which is much cheaper than the domestic original drugs. Although the price is cheap, the pharmaceutical ingredients of the Lao version of the generic medicine are basically the same as the domestic original medicine, and the efficacy is similar. Therefore, some patients may choose this generic drug as a treatment option, especially if they are on a tight budget.
Overall, selinesol, as an effective targeted therapy, has been launched in the Chinese market and included in medical insurance, helping many patients obtain treatment opportunities. Although the price of original drugs is higher, through the support of medical insurance, patients can reduce a certain financial burden during the treatment process. In addition, the Lao version of generic drugs also provides patients with a more economical choice, allowing more patients to enjoy the benefits of this treatment option.
Reference materials:https://www.selincro.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)